Loading...
XASX
IMR
Market cap452mUSD
Aug 28, Last price  
1.97AUD
Name

Imricor Medical Systems Inc

Chart & performance

D1W1MN
XASX:IMR chart
P/E
P/S
1,497.44
EPS
Div yield, %
Shrs. gr., 5y
22.11%
Rev. gr., 5y
-15.50%
Revenues
Net income
CFO

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company’s products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatible diagnostic catheter; NorthStar mapping system, a real-time, high-resolution soft tissue imaging of MRI to guide and visualize procedures with exceptional clarity; and Advantage-MR EP Recorder / Stimulator. It also offers Vision-MR Dispersive Electrode to minimize eddy currents induced on the device’s conductive pads during mr scanning. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.
IPO date
Aug 30, 2019
Employees
Domiciled in
US
Incorporated in
US

Valuation

No data to show